Perspective Therapeutics (CATX) Total Current Liabilities (2016 - 2026)

Perspective Therapeutics' Total Current Liabilities history spans 16 years, with the latest figure at $31.5 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 148.33% to $31.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $31.5 million, a 148.33% increase, with the full-year FY2025 number at $28.7 million, up 57.32% from a year prior.
  • Total Current Liabilities hit $31.5 million in Q1 2026 for Perspective Therapeutics, up from $28.7 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for CATX hit a ceiling of $31.5 million in Q1 2026 and a floor of $2.0 million in Q1 2022.
  • Historically, Total Current Liabilities has averaged $13.5 million across 5 years, with a median of $12.7 million in 2025.
  • Biggest five-year swings in Total Current Liabilities: surged 402.37% in 2023 and later decreased 26.74% in 2025.
  • Tracing CATX's Total Current Liabilities over 5 years: stood at $3.1 million in 2022, then surged by 402.37% to $15.7 million in 2023, then grew by 16.38% to $18.2 million in 2024, then soared by 57.32% to $28.7 million in 2025, then increased by 9.79% to $31.5 million in 2026.
  • Business Quant data shows Total Current Liabilities for CATX at $31.5 million in Q1 2026, $28.7 million in Q4 2025, and $20.6 million in Q3 2025.